On ECHEMI
Home > Drugs > Yabao Pharmaceutical Group Co., Ltd.
Yabao Pharmaceutical Group Co., Ltd.
  • Founded in:

    1999-01-26
  • Country:

    China China
  • Address:

    No. 43, Fumin Road, Ruicheng County, Yuncheng City, Shanxi Province
  • Tax NO.:

    91140000701108049W
  • Registered Funds:

    720,000,940 yuan
  • Website:

  • Email:

Related Drugs
Aniracetam Tablets
The main ingredient of this product is Aniracetam, whose chemical name is 1-(4-methoxybenzoyl)-2-pyrrolidone.
Name Description Content CAS NO. Registered Holders
Aniracetam

This product is a brain function improving drug, which is a cyclized derivative of γ-aminobutyric acid (GABA). This product selectively acts on the central nervous system through the blood-brain barrier. Animal experiments have shown that this product has a good promoting effect on the memory reproduction process of normal rats' discrimination learning, can counteract the memory loss caused by hypoxia, and can effectively improve memory disorders caused by certain reasons.

More

This product is a brain function improving drug, which is a cyclized derivative of γ-aminobutyric acid (GABA). This product selectively acts on the central nervous system through the blood-brain barrier. Animal experiments have shown that this product has a good promoting effect on the memory reproduction process of normal rats' discrimination learning, can counteract the memory loss caused by hypoxia, and can effectively improve memory disorders caused by certain reasons.

72432-10-1 11
Wufu Detoxification Tablets
Buffalo horn concentrated powder, Forsythia suspensa, Indigo naturalis, Coptis chinensis, Burdock fruit (fried), Scrophularia ningpoensis, Rehmannia root, Platycodon grandiflorum, Sodium sulfate, Red peony root, Licorice.
Name Description Content CAS NO. Registered Holders
water buffalo horn power

0
Forsythiae Fructus

0
NATURAL INDIGO

0
COPTIDISRHIZOMA

0
Burdock seeds (fried)

0
Scrophulariae Radix

0
REHMANNIAE RADIX PRAEPARATA

0
Platycodonis Radix

0
SODIUM SULFATE DECAHYDRATE

7727-73-3 2
Paeoniae Rubra

0
DGL

0
Detoxification and Lipid Removal Soft Capsules
Rhubarb, American ginseng, and Ophiopogon japonicus.
Name Description Content CAS NO. Registered Holders
Chrysophanic acid

481-74-3 0
AMERICAN GINSENG

0
Ophiopogonis Radix

0
Nicergoline injection
10α-Methoxy-1,6-dimethylergoline-8β-methylol-5-bromonicotinate
Name Description Content CAS NO. Registered Holders
10α-Methoxy-1,6-dimethylergoline-8β-methylol-5-bromonicotinate

This product is a semi-synthetic ergot alkaloid derivative. It has α-receptor blocking and vasodilation effects. It can enhance the metabolism of brain cell energy and increase the utilization of oxygen and glucose. It can promote the conversion of neurotransmitter dopamine to increase nerve conduction, enhance the synthesis of brain protein, and improve brain function.

More

This product is a semi-synthetic ergot alkaloid derivative. It has α-receptor blocking and vasodilation effects. It can enhance the metabolism of brain cell energy and increase the utilization of oxygen and glucose. It can promote the conversion of neurotransmitter dopamine to increase nerve conduction, enhance the synthesis of brain protein, and improve brain function.

0
Finasteride Tablets
Finasteride
Name Description Content CAS NO. Registered Holders
Finasteride

This drug belongs to the 4-nitrogen steroid hormone compound and is a specific type II 5α-reductase competitive inhibitor. It inhibits the conversion of peripheral testosterone into dihydrotestosterone and reduces the levels of dihydrotestosterone in the blood, prostate, skin and other tissues. The growth, development and benign hyperplasia of the prostate depend on dihydrotestosterone. Finasteride inhibits prostate hyperplasia by reducing the levels of dihydrotestosterone in the blood and prostate tissues, and improves the related clinical symptoms of benign prostatic hyperplasia.

More

This drug belongs to the 4-nitrogen steroid hormone compound and is a specific type II 5α-reductase competitive inhibitor. It inhibits the conversion of peripheral testosterone into dihydrotestosterone and reduces the levels of dihydrotestosterone in the blood, prostate, skin and other tissues. The growth, development and benign hyperplasia of the prostate depend on dihydrotestosterone. Finasteride inhibits prostate hyperplasia by reducing the levels of dihydrotestosterone in the blood and prostate tissues, and improves the related clinical symptoms of benign prostatic hyperplasia.

98319-26-7 50
Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.